Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephane Steurbaut

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
International Journal of Clinical Pharmacy|November 27, 2020
Spontaneous reports of adverse drug reactions related to oral anticoagulants in the Czech RepublicSimona Dvorackova, Katerina Mala-Ladova, Eva Zimcikova, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 4, 2023
Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort studyMaxim Grymonprez, Laura Carnoy, Andreas Capiau, et al.
International Journal of Clinical Pharmacy|January 23, 2021
Qualitative study of medication review in Flanders, Belgium among community pharmacists and general practitionersAnneleen Robberechts, Céline De Petter, Lindsey Van Loon, et al.
British Journal of Clinical Pharmacology|November 2, 2022
Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: A nationwide cohort studyMaxim Grymonprez, Tine L De Backer, Andreas Capiau, et al.
Thyroid : Official Journal of the American Thyroid Association|May 15, 2023
Investigating Levothyroxine Use and Its Association with Thyroid Health in Patients with Hypothyroidism: A Community Pharmacy StudyEls Mehuys, Bruno Lapauw, Guy T'Sjoen, et al.
Frontiers in Pharmacology|September 2, 2024
Use of the BRANT-MERQS scoring table for the quality assessment of type 3 medication review in patients with rheumatoid arthritis and those with type 2 diabetes mellitusAnneleen Robberechts, Kaat Stas, Margot Puttemans, et al.
International Journal of Clinical Pharmacy|September 9, 2021
A cross-sectional survey to map Clinical Pharmacy Education and Practice in EuropeLaura Moura, Stephane Steurbaut, Hege Salvesen Blix, et al.
Frontiers in Pharmacology|October 8, 2024
Case report: A case of severe capecitabine toxicity due to confirmed in trans compound heterozygosity of a common and rare DPYD variantAmy de Haar-Holleman, Pieter-Jan Cortoos, Jelle Vlaeminck, et al.
Cardiovascular Drugs and Therapy|November 6, 2023
Pharmacodynamic Drug-Drug Interactions and Bleeding Outcomes in Patients with Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants: a Nationwide Cohort StudyMaxim Grymonprez, Andreas Capiau, Stephane Steurbaut, et al.
Patient Education and Counseling|July 6, 2020
Association of conflicting information from healthcare providers and poor shared decision making with suboptimal adherence in direct oral anticoagulant treatment: A cross-sectional study in patients with atrial fibrillationSouad Moudallel, Bart J F van den Bemt, Hanneke Zwikker, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
International Journal of Clinical Pharmacy|November 27, 2020
Spontaneous reports of adverse drug reactions related to oral anticoagulants in the Czech RepublicSimona Dvorackova, Katerina Mala-Ladova, Eva Zimcikova, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 4, 2023
Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort studyMaxim Grymonprez, Laura Carnoy, Andreas Capiau, et al.
International Journal of Clinical Pharmacy|January 23, 2021
Qualitative study of medication review in Flanders, Belgium among community pharmacists and general practitionersAnneleen Robberechts, Céline De Petter, Lindsey Van Loon, et al.
British Journal of Clinical Pharmacology|November 2, 2022
Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: A nationwide cohort studyMaxim Grymonprez, Tine L De Backer, Andreas Capiau, et al.
Thyroid : Official Journal of the American Thyroid Association|May 15, 2023
Investigating Levothyroxine Use and Its Association with Thyroid Health in Patients with Hypothyroidism: A Community Pharmacy StudyEls Mehuys, Bruno Lapauw, Guy T'Sjoen, et al.
Frontiers in Pharmacology|September 2, 2024
Use of the BRANT-MERQS scoring table for the quality assessment of type 3 medication review in patients with rheumatoid arthritis and those with type 2 diabetes mellitusAnneleen Robberechts, Kaat Stas, Margot Puttemans, et al.
International Journal of Clinical Pharmacy|September 9, 2021
A cross-sectional survey to map Clinical Pharmacy Education and Practice in EuropeLaura Moura, Stephane Steurbaut, Hege Salvesen Blix, et al.
Frontiers in Pharmacology|October 8, 2024
Case report: A case of severe capecitabine toxicity due to confirmed in trans compound heterozygosity of a common and rare DPYD variantAmy de Haar-Holleman, Pieter-Jan Cortoos, Jelle Vlaeminck, et al.
Cardiovascular Drugs and Therapy|November 6, 2023
Pharmacodynamic Drug-Drug Interactions and Bleeding Outcomes in Patients with Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants: a Nationwide Cohort StudyMaxim Grymonprez, Andreas Capiau, Stephane Steurbaut, et al.
Patient Education and Counseling|July 6, 2020
Association of conflicting information from healthcare providers and poor shared decision making with suboptimal adherence in direct oral anticoagulant treatment: A cross-sectional study in patients with atrial fibrillationSouad Moudallel, Bart J F van den Bemt, Hanneke Zwikker, et al.
Pageof 7